372
Views
19
CrossRef citations to date
0
Altmetric
Original Article

Small intestinal bacterial overgrowth is associated with Diarrhea-predominant irritable bowel syndrome by increasing mainly Prevotella abundance

, , , , &
Pages 1419-1425 | Received 08 Sep 2019, Accepted 11 Nov 2019, Published online: 25 Nov 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Priyankar Dey & Saumya Ray Chaudhuri. (2023) The opportunistic nature of gut commensal microbiota. Critical Reviews in Microbiology 49:6, pages 739-763.
Read now
Jun-Jie Hou, Xin Wang, Yu-Ming Wang & Bang-Mao Wang. (2022) Interplay between gut microbiota and bile acids in diarrhoea-predominant irritable bowel syndrome: a review. Critical Reviews in Microbiology 48:6, pages 696-713.
Read now

Articles from other publishers (17)

Gernot Sellge. (2024) Ernährung bei bakterieller Fehlbesiedlung des DünndarmsRole of nutrition in bacterial overgrowth of the small intestine. Die Gastroenterologie 19:1, pages 22-29.
Crossref
Negin Kazemian, Tony Zhou, Naveen Chalasani, Apurva Narayan, Jose Guillermo Cedeño Laurent, Hector A. Olvera Alvarez & Sepideh Pakpour. (2024) Long-Term Impact of Childhood Adversity on the Gut Microbiome of Nursing Students. International Journal of Environmental Research and Public Health 21:1, pages 68.
Crossref
Maria Napolitano, Ernesto Fasulo, Federica Ungaro, Luca Massimino, Emanuele Sinagra, Silvio Danese & Francesco Vito Mandarino. (2023) Gut Dysbiosis in Irritable Bowel Syndrome: A Narrative Review on Correlation with Disease Subtypes and Novel Therapeutic Implications. Microorganisms 11:10, pages 2369.
Crossref
Jing Sun, Mengqiu Zhang, Wei Liu, Youqian Liu, Dongjian Zhang, Xinyu Fan, Jian Zhang, Tian Li & Min Lu. (2023) Evaluation of the effectiveness and mechanism of action of the Chang-Kang-Fang formula combined with bifid triple viable capsules on diarrhea-predominant irritable bowel syndrome. Frontiers in Microbiology 14.
Crossref
Karen Delbaere, Inez Roegiers, Auriane Bron, Claude Durif, Tom Van de Wiele, Stéphanie Blanquet-Diot & Ludovica Marinelli. (2023) The small intestine: dining table of host–microbiota meetings. FEMS Microbiology Reviews 47:3.
Crossref
Rachel P. Sarnoff, Ravi R. Bhatt, Vadim Osadchiy, Tien Dong, Jennifer S. Labus, Lisa A. Kilpatrick, Zixi Chen, Vishvak Subramanyam, Yurui Zhang, Benjamin M. Ellingson, Bruce Naliboff, Lin Chang, Emeran A. Mayer & Arpana Gupta. (2023) A multi-omic brain gut microbiome signature differs between IBS subjects with different bowel habits. Neuropharmacology 225, pages 109381.
Crossref
绪 罗. (2023) Research Progress on the Relationship between Irritable Bowel Syndrome and Small Intestinal Bacterial Overgrowth. Advances in Clinical Medicine 13:08, pages 13555-13560.
Crossref
Chengjiao Yao, Yilin Li, Lihong Luo, Fengjiao Xie, Qin Xiong, Tinglin Li, Chunrong Yang & Pei-min Feng. (2022) Significant Differences in Gut Microbiota Between Irritable Bowel Syndrome with Diarrhea and Healthy Controls in Southwest China. Digestive Diseases and Sciences 68:1, pages 106-127.
Crossref
Roman Maslennikov, Vladimir Ivashkin, Irina Efremova, Elena Poluektova, Anna Kudryavtseva & George Krasnov. (2022) Gut dysbiosis and small intestinal bacterial overgrowth as independent forms of gut microbiota disorders in cirrhosis. World Journal of Gastroenterology 28:10, pages 1067-1077.
Crossref
Zuojing Liu, Shiwei Zhu, Meibo He, Mo Li, Hui Wei, Lu Zhang, Qinghua Sun, Qiong Jia, Nan Hu, Yuan Fang, Lijin Song, Chen Zhou, Heqing Tao, John Y Kao, Huaiqiu Zhu, Chung Owyang & Liping Duan. (2022) Patients with breath test positive are necessary to be identified from irritable bowel syndrome: a clinical trial based on microbiomics and rifaximin sensitivity. Chinese Medical Journal 135:14, pages 1716-1727.
Crossref
Fenghua Xu, Ning Li, Chun Wang, Hanyang Xing, Dongfeng Chen & Yanling Wei. (2021) Clinical efficacy of fecal microbiota transplantation for patients with small intestinal bacterial overgrowth: a randomized, placebo-controlled clinic study. BMC Gastroenterology 21:1.
Crossref
Jun-Jie Hou, Xin Wang, Ying Li, Shuai Su, Yu-Ming Wang & Bang-Mao Wang. (2021) The relationship between gut microbiota and proteolytic activity in irritable bowel syndrome. Microbial Pathogenesis 157, pages 104995.
Crossref
Jiaqu Cui, Zhiliang Lin, Hongliang Tian, Bo Yang, Di Zhao, Chen Ye, Ning Li, Huanlong Qin & Qiyi Chen. (2021) Long-Term Follow-Up Results of Fecal Microbiota Transplantation for Irritable Bowel Syndrome: A Single-Center, Retrospective Study. Frontiers in Medicine 8.
Crossref
Nicolas Richard, Charlotte Desprez, Fabien Wuestenberghs, Anne‐Marie Leroi, Guillaume Gourcerol & Chloé Melchior. (2021) The effectiveness of rotating versus single course antibiotics for small intestinal bacterial overgrowth. United European Gastroenterology Journal 9:6, pages 645-654.
Crossref
Yann Nguyen, Xavier Mariette, Carine Salliot, Gaëlle Gusto, Marie-Christine Boutron-Ruault & Raphaèle Seror. (2020) Chronic diarrhoea and risk of rheumatoid arthritis: findings from the French E3N-EPIC Cohort Study. Rheumatology 59:12, pages 3767-3775.
Crossref
Will Takakura & Mark Pimentel. (2020) Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome – An Update. Frontiers in Psychiatry 11.
Crossref
Damian Jacenik & Marta Zielińska. 2020. A Comprehensive Overview of Irritable Bowel Syndrome. A Comprehensive Overview of Irritable Bowel Syndrome 57 68 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.